Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Hydralazine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 223Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of June 7, 2023
    Enforcement Report - Week of June 7, 2023

    07 Jun 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf

    FDA
    07 Jun 2023
    Share Share
    Generic Drugmaker Admits to Price Fixing
    Generic Drugmaker Admits to Price Fixing

    01 Jun 2019

    // Zachary Brennan RAPS

    https://www.raps.org/news-and-articles/news-articles/2019/5/generic-drugmaker-admits-to-price-fixing

    Zachary Brennan RAPS
    01 Jun 2019
    Share Share
    When a Study Cast Doubt on a Heart Pill, the Drug Company Turned to Tom Price
    When a Study Cast Doubt on a Heart Pill, the Drug Company Turned to Tom Price

    20 Jan 2017

    // Robert Faturechi PROPUBLICA

    https://www.propublica.org/article/when-a-study-cast-doubt-on-heart-pill-the-drug-company-turned-to-tom-price

    Robert Faturechi PROPUBLICA
    20 Jan 2017
    Share Share
    These 10 Drugs Are Busting Hospital Budgets
    These 10 Drugs Are Busting Hospital Budgets

    12 Oct 2016

    // Bruce Japsen FORBES

    http://www.forbes.com/sites/brucejapsen/2016/10/12/these-10-drugs-are-busting-hospital-budgets/#4ae9da803d29

    Bruce Japsen FORBES
    12 Oct 2016
    Share Share
    Mylan Launches Generic Apresoline® Injection
    Mylan Launches Generic Apresoline® Injection

    05 May 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/mylan-launches-generic-apresoline-injection-300263099.html

    PR NEWSWIRE
    05 May 2016
    Share Share
    X-Gen's Generic Hydralazine Hcl (20Mg/Ml) Approved in US For Hypertension
    X-Gen's Generic Hydralazine Hcl (20Mg/Ml) Approved in US For Hypertension

    02 Jul 2015

    // FDA

    https://www.pharmacompass.com/pdf/news/x-gens-generic-hydralazine-hcl-20mgml-approved-in-us-for-hypertension-1435840480.pdf

    FDA
    02 Jul 2015
    Share Share